Alexandria Real Estate Equities
ARE
#2319
Rank
NZ$13.60 B
Marketcap
NZ$78.73
Share price
-2.38%
Change (1 day)
-54.03%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) Fails to deliver data

Key failure to deliver metrics for Alexandria Real Estate Equities :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013

Volume in USD (price x number of shares), data since 2013

Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$31.01 M-48.72%
2024NZ$60.47 M46.83%
2023NZ$41.18 M-64.08%
2022NZ$0.11 B22.18%
2021NZ$93.85 M-16.64%
2020NZ$0.11 B38.94%
2019NZ$81.03 M-10.89%
2018NZ$90.94 M-43.57%
2017NZ$0.16 B192.01%
2016NZ$55.19 M125.93%
2015NZ$24.42 M11.4%
2014NZ$21.92 M875.57%
2013NZ$2.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
NZ$24.63 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$60.15 MNZ$0.26 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$0.21 BNZ$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$5.81 MNZ$28.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.09 MNZ$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$5.75 MNZ$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$13.72 MNZ$39.91 M๐Ÿ‡บ๐Ÿ‡ธ USA